These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22511364)

  • 1. Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder.
    Strawn JR; Wehry AM; DelBello MP; Rynn MA; Strakowski S
    Depress Anxiety; 2012 Apr; 29(4):328-39. PubMed ID: 22511364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacologic treatment of children and adolescents with anxiety disorders.
    Strawn JR; Sakolsky DJ; Rynn MA
    Child Adolesc Psychiatr Clin N Am; 2012 Jul; 21(3):527-39. PubMed ID: 22800992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional anatomy, neurochemistry, and pharmacology of anxiety.
    Ninan PT
    J Clin Psychiatry; 1999; 60 Suppl 22():12-7. PubMed ID: 10634350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary investigation of neural correlates of treatment in adolescents with generalized anxiety disorder.
    Maslowsky J; Mogg K; Bradley BP; McClure-Tone E; Ernst M; Pine DS; Monk CS
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):105-11. PubMed ID: 20415605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and treatment of anxiety disorders in children and adolescents.
    Wehry AM; Beesdo-Baum K; Hennelly MM; Connolly SD; Strawn JR
    Curr Psychiatry Rep; 2015 Jul; 17(7):52. PubMed ID: 25980507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocircuitry of generalized anxiety disorder in adolescents: a pilot functional neuroimaging and functional connectivity study.
    Strawn JR; Bitter SM; Weber WA; Chu WJ; Whitsel RM; Adler C; Cerullo MA; Eliassen J; Strakowski SM; DelBello MP
    Depress Anxiety; 2012 Nov; 29(11):939-47. PubMed ID: 22628125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options: Addressing the current dilemma.
    Dinan T
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S119-27. PubMed ID: 16730164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of generalized anxiety disorder.
    Gorman JM
    J Clin Psychiatry; 2002; 63 Suppl 8():17-23. PubMed ID: 12044104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.
    Gomez AF; Barthel AL; Hofmann SG
    Expert Opin Pharmacother; 2018 Jun; 19(8):883-894. PubMed ID: 29806492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment for generalized anxiety disorder in adults: an update.
    Reinhold JA; Rickels K
    Expert Opin Pharmacother; 2015; 16(11):1669-81. PubMed ID: 26159446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.
    Lu L; Mills JA; Li H; Schroeder HK; Mossman SA; Varney ST; Cecil KM; Huang X; Gong Q; Ramsey LB; DelBello MP; Sweeney JA; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Oct; 60(10):1309-1318. PubMed ID: 33548492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder.
    Monk CS; Telzer EH; Mogg K; Bradley BP; Mai X; Louro HM; Chen G; McClure-Tone EB; Ernst M; Pine DS
    Arch Gen Psychiatry; 2008 May; 65(5):568-76. PubMed ID: 18458208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
    Strawn JR; Geracioti L; Rajdev N; Clemenza K; Levine A
    Expert Opin Pharmacother; 2018 Jul; 19(10):1057-1070. PubMed ID: 30056792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WCA recommendations for the long-term treatment of generalized anxiety disorder.
    Allgulander C; Bandelow B; Hollander E; Montgomery SA; Nutt DJ; Okasha A; Pollack MH; Stein DJ; Swinson RP;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):53-61. PubMed ID: 14767398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the neurobiological basis of anxiety disorders.
    Gorman JM; Hirschfeld RM; Ninan PT
    Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting pharmacotherapy for generalized anxiety disorder.
    Goodman WK
    J Clin Psychiatry; 2004; 65 Suppl 13():8-13. PubMed ID: 15384931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.
    Wang Z; Whiteside SPH; Sim L; Farah W; Morrow AS; Alsawas M; Barrionuevo P; Tello M; Asi N; Beuschel B; Daraz L; Almasri J; Zaiem F; Larrea-Mantilla L; Ponce OJ; LeBlanc A; Prokop LJ; Murad MH
    JAMA Pediatr; 2017 Nov; 171(11):1049-1056. PubMed ID: 28859190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater Dynamic and Lower Static Functional Brain Connectivity Prospectively Predict Placebo Response in Pediatric Generalized Anxiety Disorder.
    Lu L; Li H; Mills JA; Schroeder H; Mossman SA; Varney ST; Cecil KM; Huang X; Gong Q; Levine A; DelBello MP; Sweeny JA; Strawn JR
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):606-616. PubMed ID: 32721213
    [No Abstract]   [Full Text] [Related]  

  • 19. Current and Novel Psychopharmacological Drugs for Anxiety Disorders.
    Bandelow B
    Adv Exp Med Biol; 2020; 1191():347-365. PubMed ID: 32002937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current considerations in the treatment of generalized anxiety disorder.
    Katzman MA
    CNS Drugs; 2009; 23(2):103-20. PubMed ID: 19173371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.